- Home
- / Shuttle Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shuttle Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.8
2024-10-29
Market Capitalization
$5.3 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Cost of goods sold | 142.0K | |||
| General and administrative expense | 199.0K | 1.0M | 1.4M | 5.7M |
| Operating expense total | 1.7M | 4.6M | 5.0M | 9.7M |
| EBIT | (2.6M) | (5.9M) | (7.7M) | (11.9M) |
| Interest income | 79.1K | 38.1K | 1.1K | |
| Interest expense | 2.1M | 100.0K | ||
| Pre tax profit | (3.0M) | (6.6M) | 11.4M | |
| Income tax expense | 5.9M | 10.9M | 26.3M | |
| Net Income | (3.0M) | (6.6M) | (9.5M) | (11.7M) |
| EPS | (3.5) | (3.3) | (7.2) |